Pulmonary capillary haemangiomatosis in children and adolescents: Report of a new case and a review of the literature

Katalin Bartyik, Olga Bede, L. Tiszlavicz, Beata Onozo, Istvan Virag, S. Túri

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Pulmonary capillary haemangiomatosis (PCH) in childhood is a rarity, characterised by the uncontrolled proliferation of pulmonary microvessels which may invade pulmonary, bronchial and vascular structures, resulting in diffuse alveolar haemorrhage, manifesting clinically in haemoptysis, dyspnoea and symptoms of pulmonary hypertension (PH). A 14-year-old boy with some particular features (pericardial effusion and thrombocytopenia) is presented and 14 paediatric/adolescent cases from the literature are surveyed. The diagnostic problems and difficulties are discussed, including the importance of imaging (high-resolution CT) and histopathological studies, with the aim of providing a clear-cut distinction of PCH from other conditions such as primary PH (PPH). The literature data can be regarded as ambiguous: both similarities and relatively sharp distinctions between PCH and PPH are to be found. New developments in the field of genetics are also discussed. The early coexistence of PCH and other (vascular) disorders and associations, involving focal or diffuse, disseminated forms is summarised briefly. Conclusion: The diagnosis of this progressive disorder may lead to effective therapy. Treatment possibilities include the rapidly evolving field of anti-angiogenic therapy, but at present lung transplantation is universally accepted as the final definitive treatment for pulmonary capillary haemangiomatosis.

Original languageEnglish
Pages (from-to)731-737
Number of pages7
JournalEuropean Journal of Pediatrics
Volume163
Issue number12
DOIs
Publication statusPublished - Dec 2004

Fingerprint

Lung
Blood Vessels
Pericardial Effusion
Lung Transplantation
Hemoptysis
Therapeutics
Microvessels
Pulmonary Hypertension
Thrombocytopenia
Dyspnea
Pediatrics
Hemorrhage

Keywords

  • Adolescents
  • Children
  • Primary pulmonary hypertension
  • Pulmonary capillary haemangiomatosis
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pulmonary capillary haemangiomatosis in children and adolescents : Report of a new case and a review of the literature. / Bartyik, Katalin; Bede, Olga; Tiszlavicz, L.; Onozo, Beata; Virag, Istvan; Túri, S.

In: European Journal of Pediatrics, Vol. 163, No. 12, 12.2004, p. 731-737.

Research output: Contribution to journalArticle

@article{6f54f514060b498ea05b3d32c940ee92,
title = "Pulmonary capillary haemangiomatosis in children and adolescents: Report of a new case and a review of the literature",
abstract = "Pulmonary capillary haemangiomatosis (PCH) in childhood is a rarity, characterised by the uncontrolled proliferation of pulmonary microvessels which may invade pulmonary, bronchial and vascular structures, resulting in diffuse alveolar haemorrhage, manifesting clinically in haemoptysis, dyspnoea and symptoms of pulmonary hypertension (PH). A 14-year-old boy with some particular features (pericardial effusion and thrombocytopenia) is presented and 14 paediatric/adolescent cases from the literature are surveyed. The diagnostic problems and difficulties are discussed, including the importance of imaging (high-resolution CT) and histopathological studies, with the aim of providing a clear-cut distinction of PCH from other conditions such as primary PH (PPH). The literature data can be regarded as ambiguous: both similarities and relatively sharp distinctions between PCH and PPH are to be found. New developments in the field of genetics are also discussed. The early coexistence of PCH and other (vascular) disorders and associations, involving focal or diffuse, disseminated forms is summarised briefly. Conclusion: The diagnosis of this progressive disorder may lead to effective therapy. Treatment possibilities include the rapidly evolving field of anti-angiogenic therapy, but at present lung transplantation is universally accepted as the final definitive treatment for pulmonary capillary haemangiomatosis.",
keywords = "Adolescents, Children, Primary pulmonary hypertension, Pulmonary capillary haemangiomatosis, Pulmonary hypertension",
author = "Katalin Bartyik and Olga Bede and L. Tiszlavicz and Beata Onozo and Istvan Virag and S. T{\'u}ri",
year = "2004",
month = "12",
doi = "10.1007/s00431-004-1527-5",
language = "English",
volume = "163",
pages = "731--737",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Pulmonary capillary haemangiomatosis in children and adolescents

T2 - Report of a new case and a review of the literature

AU - Bartyik, Katalin

AU - Bede, Olga

AU - Tiszlavicz, L.

AU - Onozo, Beata

AU - Virag, Istvan

AU - Túri, S.

PY - 2004/12

Y1 - 2004/12

N2 - Pulmonary capillary haemangiomatosis (PCH) in childhood is a rarity, characterised by the uncontrolled proliferation of pulmonary microvessels which may invade pulmonary, bronchial and vascular structures, resulting in diffuse alveolar haemorrhage, manifesting clinically in haemoptysis, dyspnoea and symptoms of pulmonary hypertension (PH). A 14-year-old boy with some particular features (pericardial effusion and thrombocytopenia) is presented and 14 paediatric/adolescent cases from the literature are surveyed. The diagnostic problems and difficulties are discussed, including the importance of imaging (high-resolution CT) and histopathological studies, with the aim of providing a clear-cut distinction of PCH from other conditions such as primary PH (PPH). The literature data can be regarded as ambiguous: both similarities and relatively sharp distinctions between PCH and PPH are to be found. New developments in the field of genetics are also discussed. The early coexistence of PCH and other (vascular) disorders and associations, involving focal or diffuse, disseminated forms is summarised briefly. Conclusion: The diagnosis of this progressive disorder may lead to effective therapy. Treatment possibilities include the rapidly evolving field of anti-angiogenic therapy, but at present lung transplantation is universally accepted as the final definitive treatment for pulmonary capillary haemangiomatosis.

AB - Pulmonary capillary haemangiomatosis (PCH) in childhood is a rarity, characterised by the uncontrolled proliferation of pulmonary microvessels which may invade pulmonary, bronchial and vascular structures, resulting in diffuse alveolar haemorrhage, manifesting clinically in haemoptysis, dyspnoea and symptoms of pulmonary hypertension (PH). A 14-year-old boy with some particular features (pericardial effusion and thrombocytopenia) is presented and 14 paediatric/adolescent cases from the literature are surveyed. The diagnostic problems and difficulties are discussed, including the importance of imaging (high-resolution CT) and histopathological studies, with the aim of providing a clear-cut distinction of PCH from other conditions such as primary PH (PPH). The literature data can be regarded as ambiguous: both similarities and relatively sharp distinctions between PCH and PPH are to be found. New developments in the field of genetics are also discussed. The early coexistence of PCH and other (vascular) disorders and associations, involving focal or diffuse, disseminated forms is summarised briefly. Conclusion: The diagnosis of this progressive disorder may lead to effective therapy. Treatment possibilities include the rapidly evolving field of anti-angiogenic therapy, but at present lung transplantation is universally accepted as the final definitive treatment for pulmonary capillary haemangiomatosis.

KW - Adolescents

KW - Children

KW - Primary pulmonary hypertension

KW - Pulmonary capillary haemangiomatosis

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=11244306613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11244306613&partnerID=8YFLogxK

U2 - 10.1007/s00431-004-1527-5

DO - 10.1007/s00431-004-1527-5

M3 - Article

C2 - 15365825

AN - SCOPUS:11244306613

VL - 163

SP - 731

EP - 737

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 12

ER -